Farsalinos K

References (4)

Title : Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions - Alexandris_2021_Toxicol.Rep_8_73
Author(s) : Alexandris N , Lagoumintzis G , Chasapis CT , Leonidas DD , Papadopoulos GE , Tzartos SJ , Tsatsakis A , Eliopoulos E , Poulas K , Farsalinos K
Ref : Toxicol Rep , 8 :73 , 2021
Abstract : Alexandris_2021_Toxicol.Rep_8_73
ESTHER : Alexandris_2021_Toxicol.Rep_8_73
PubMedSearch : Alexandris_2021_Toxicol.Rep_8_73
PubMedID: 33425684

Title : COVID-19 and the nicotinic cholinergic system - Farsalinos_2020_Eur.Respir.J_56_
Author(s) : Farsalinos K , Angelopoulou A , Alexandris N , Poulas K
Ref : Eur Respir J , 56 : , 2020
Abstract : Farsalinos_2020_Eur.Respir.J_56_
ESTHER : Farsalinos_2020_Eur.Respir.J_56_
PubMedSearch : Farsalinos_2020_Eur.Respir.J_56_
PubMedID: 32444400

Title : Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications - Farsalinos_2020_Int.J.Mol.Sci_21_
Author(s) : Farsalinos K , Eliopoulos E , Leonidas DD , Papadopoulos GE , Tzartos S , Poulas K
Ref : Int J Mol Sci , 21 : , 2020
Abstract : Farsalinos_2020_Int.J.Mol.Sci_21_
ESTHER : Farsalinos_2020_Int.J.Mol.Sci_21_
PubMedSearch : Farsalinos_2020_Int.J.Mol.Sci_21_
PubMedID: 32823591

Title : Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system -
Author(s) : Farsalinos K , Niaura R , Le Houezec J , Barbouni A , Tsatsakis A , Kouretas D , Vantarakis A , Poulas K
Ref : Toxicol Rep , 7 :658 , 2020
PubMedID: 32355638